Episode Details

Back to Episodes
China NMPA's Revised GMP: What Manufacturers Must Do by the November 2026 Deadline

China NMPA's Revised GMP: What Manufacturers Must Do by the November 2026 Deadline

Published 2 days, 19 hours ago
Description
China's National Medical Products Administration (NMPA) is enforcing a revised Good Manufacturing Practice (GMP) for medical devices, with a compliance deadline of November 1, 2026. This episode explores the first major update to China's quality system regulations since 2014, detailing the stricter requirements for risk management, supplier controls, and contract manufacturing. We also discuss the NMPA's recent increase in enforcement actions against foreign manufacturers and provide practical steps for quality and regulatory teams to prepare for the deadline. Key Questions: - What are the most significant changes in China's revised GMP for medical devices? - When is the final deadline for manufacturers to comply with the new NMPA regulations? - How does the new GMP impact quality assurance and risk management processes? - What new requirements apply to contract manufacturing and supplier controls? - Why are foreign medical device manufacturers facing increased scrutiny from the NMPA? - What recent enforcement actions signal a stricter regulatory environment in China? - What practical steps should my team take to perform a gap analysis against the new GMP? - How can we prepare our quality management system for NMPA inspections under the new rules? Sources: - https://www.emergobyul.com/news/china-nmpa-quality-management-system-qms-legislation-take-effect-november-1-2026 - https://chinameddevice.com/chinas-2026-new-gmp-will-your-quality-system-pass-the-nmpa-inspection/ - https://regdesk.co/chinas-nmpa-releases-39-updated-medical-device-registration-guidelines/ - https://www.nmpa.gov.cn/english/medicaldevices/202601/t20260101_12345.html How Pure Global can help: Pure Global provides end-to-end regulatory consulting for MedTech and IVD companies, helping you navigate complex requirements like China's NMPA GMP. Our local experts in China and advanced AI tools can streamline your gap analysis, QMS remediation, and technical dossier submissions to ensure compliance by the 2026 deadline. We act as your local representative, manage submissions, and provide continuous regulatory monitoring to maintain your market presence. To learn how we can accelerate your access to over 30 global markets, visit us at https://pureglobal.com, contact info@pureglobal.com, or explore our free AI tools and device database at https://pureglobal.ai.
Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us